TABLE II. Characteristics of Patients with Net of the Colon and RECTUM According to KI-67 Proliferation Index.

Tumor no.	Origin	Behavior	Ki-67	CIMP	LOH (marker)	MSI (marker)	Follow-up time (weeks)	Survival	Gender	Age at diagnosis
17	Colon	Malignant	<2	−	−	MSI-H (BAT25, D17S250)	na	na	f	70
14	Colon	Malignant	3	+	+ (D11S913)	MSI-L	8	Survived	f	62
12	Colon	Malignant	5	+	+ (D2S123, PYGM, RH-93814)	MSS	27	Survived	f	77
13	Colon	Malignant	5	+	+ (D17S250, PYGM)	MSI-L	8	tu	f	54
18	Colon	Malignant	20	+	+ D11S913	MSS	na	na	m	70
23	Colon	Malignant	30	+	+ (D11S913)	MSS	19	tu	m	32
11	Colon	Malignant	40	−	−	MSI-L	18	Survived	m	67
32	Colon	Malignant	45	−	na	MSS	62	Survived	m	54
33	Colon	Malignant	45	+	−	Na	46	tu	f	58
9	Colon	Malignant	50	+	+ (RH-93814)	Na	na	na	na	na
10	Colon	Malignant	50	+	−	Na	15	Survived	m	71
16	Colon	Malignant	50	+	−	MSS	na	na	f	57
19	Colon	Malignant	50	−	−	MSS	na	na	na	na
21	Colon	Malignant	50	+	−	MSS	13	tu	m	69
27	Colon	Malignant	50	+	−	MSS	14	tu	m	32
5	Colon	Malignant	50	+	−	Na	na	na	na	na
6	Colon	Malignant	60	−	−	Na	na	na	na	na
25	Colon	Malignant	60	+	−	MSS	0	tu	f	63
8	Colon	Malignant	60	+	−	MSS	99	Survived	m	74
1	Colon	Malignant	65	+	−	MSI-L	na	Na	na	na
34	Colon	Malignant	65	−	na	Na	38	Survived	m	56
2	Colon	Malignant	70	+	−	MSS	na	Na	na	na
29	Colon	Malignant	75	+	na	MSS	2	Tu	m	64
30	Colon	Malignant	75	−	na	MSS	1	Tu	f	92
7	Colon	Malignant	80	−	−	MSI-L	na	Na	na	na
15	Colon	Malignant	80	+	−	MSS	2	Tu	m	53
3	Colon	Malignant	85	−	na	na	na	na	na	na
31	Colon	Malignant	85	−	na	MSS	68	Survived	f	58
4	Colon	Malignant	90	−	na	na	na	na	na	na
22	Colon	Malignant	90	+	+ (D5S346, D11S913)	MSS	57	tu	m	49
28	Rectum	Malignant	<2	−	−	MSS	6	tu	m	55
24	Rectum	Malignant	50	+	−	MSS	13	tu	m	29
26	Rectum	Malignant	50	−	−	MSI-L	7	tu	m	57
20	Rectum	Malignant	90	−	+ (D11S913)	MSS	8	tu	f	81

na, not available; tu, died from the tumor; f, female; m, male.